These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26365216)

  • 1. Major bleeding in hemodialysis patients using unfractionated or low molecular weight heparin: a single-center study.
    Nadarajah L; Fan S; Forbes S; Ashman N
    Clin Nephrol; 2015 Nov; 84(5):274-9. PubMed ID: 26365216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis.
    Lazrak HH; René É; Elftouh N; Leblanc M; Lafrance JP
    BMC Nephrol; 2017 Jun; 18(1):187. PubMed ID: 28592259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporotic fracture rates in chronic hemodialysis and effect of heparin exposure: a retrospective cohort study.
    Harrak H; René E; Alsalemi N; Elftouh N; Lafrance JP
    BMC Nephrol; 2020 Jul; 21(1):261. PubMed ID: 32646504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and low molecular weight heparin in older people in a hospital with ambulatory care.
    Chan DK; Ong B; Almafragy H; Karr M; Hung AW; Liu JG
    Arch Gerontol Geriatr; 2006; 43(2):233-41. PubMed ID: 16359739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Low-Molecular-Weight Heparin and Risk of Bleeding Among Hemodialysis Patients: A Retrospective Cohort Study.
    Lazrak HH; René E; Elftouh N; Lafrance JP
    Can J Kidney Health Dis; 2018; 5():2054358118792010. PubMed ID: 30116544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.
    Palmer AJ; Koppenhagen K; Kirchhof B; Weber U; Bergemann R
    Haemostasis; 1997; 27(2):75-84. PubMed ID: 9212355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
    Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
    Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: the FAST-MI registry.
    Puymirat É; Aissaoui N; Silvain J; Bonello L; Cuisset T; Motreff P; Bataille V; Durand E; Cottin Y; Simon T; Danchin N;
    Arch Cardiovasc Dis; 2012; 105(6-7):347-54. PubMed ID: 22800719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major bleeding in hemodialysis patients.
    Holden RM; Harman GJ; Wang M; Holland D; Day AG
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):105-10. PubMed ID: 18003768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different bridging anticoagulation therapies used after mechanical heart valve replacement in Chinese patients - a prospective cohort study.
    Li BX; Liu SD; Qi L; Sun S; Sun W; Li YM; Song B; Wu XA
    J Cardiothorac Surg; 2020 Feb; 15(1):40. PubMed ID: 32093747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency.
    Park D; Southern W; Calvo M; Kushnir M; Solorzano C; Sinnet M; Billett HH
    J Gen Intern Med; 2016 Feb; 31(2):182-187. PubMed ID: 26209179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients.
    Volteas P; Drakos P; Alkadaa LN; Cleri NA; Asencio AA; Oganov A; Giannopoulos S; Saadon JR; Mikell CB; Rubano JA; Labropoulos N; Tassiopoulos AK; Mofakham S; Bannazadeh M
    J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1128-1136. PubMed ID: 35716998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates.
    Elliott MJ; Zimmerman D; Holden RM
    Am J Kidney Dis; 2007 Sep; 50(3):433-40. PubMed ID: 17720522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.